• Home
  • Routine Haematology

Apixaban and Rivaroxaban Assays

Haematology are now offering assays to measure the new oral anticoagulant drugs Apixaban and Rivaroxaban. Both drugs are direct factor Xa inhibitors. Apixaban is recommended by the National Institute for Health and Clinical Excellence for the prevention of stroke and systemic embolism in people with non-valvular atrial fibrillation and at least one of the following risk factors: prior stroke or transient ischemic attack, age 75 years or older, diabetes mellitus, or symptomatic heart failure. Apixaban and other newer anticoagulants (dabigatran and rivaroxaban) appear equally effective as warfarin in preventing non-hemorrhagic stroke in people with atrial fibrillation and are associated with lower risk of intracranial bleeding. For further information please contact the laboratory on 0121 424 0908 (internal ext 40908) or for clinical advice please contact the On Call Haematologist via switchboard.

  • Created on .
  • Last updated on .

Routine Diagnostic Service (Haematology)

Routine Requests

Internal requests should be made using either the combined paper request form, for Haematology, Clinical Chemistry and Immunology, which should be filled out 'lottery style', or the Trusts electronic system for requesting and reporting, ICE, which can be navigated to from the Trust Intranet home page. For data quality purposes, Laboratory Medicine encourage all users to use ICE. GP requests should be made using the GP combined request form again using 'lottery style' tick boxes.

Click here for further information on completing request forms.

Routine results are avaliable the same day. Coagulation results for anticoagulation control will be available within 4hours of receipt in the laboratory. When abnormal results are detected, every attempt is made to contact the requestor. Where appropriate the Consultant Haematologist or registrar will contact the requestor direct with advice regarding patient care.

Sample Integrity

Poorly venepunctured blood samples can dramatically affect the results of a test. Some of the more common errors are listed below:

Read more: Routine Diagnostic Service (Haematology)

  • Created on .
  • Last updated on .

The laboratories at Heartlands Hospital, Good Hope Hospital and Solihull Hospital form part of the services provided by University Hospitals Birmingham and are UKAS (United Kingdom Accreditation Service) accredited to the ISO 15189:2012 standard. For a list of accredited tests and other information please visit the UKAS website using the following link: https://www.ukas.com/find-an-organisation/

  • Heartlands, Good Hope and Solihull Hospital pathology laboratories are a UKAS accredited medical laboratory No.8217
  • United Kingdom Health Security Agency laboratory is a UKAS accredited medical laboratory No.8213

Tests not appearing on the UKAS Schedule of Accreditation currently remain outside of our scope of accreditation. However, these tests have been validated to the same high standard as accredited tests and are performed by the same trained and competent staff.

For further test information, please visit the test database: http://www.heftpathology.com/frontpage/test-database.html.

Protection of personal information - Laboratory Medicine comply with the Trust Data Protection policy and have procedures in place to allow the Directorate and its employees to comply with the Data Protection act  1998 and associated best practice and guidance.

For further information contact Louise Fallon, Quality Manager, 0121 424 1235

UKAS HEFT